Next-generation diagnostics with eye-tracking
Our Clinical Importance
Dr. Bjørn Helland-Hansen introducing Bulbitech’s technology and explaining the importance of having one single device available in daily clinical practice supporting eye doctors in a complete neuro-ophthalmic assessment of the patient.
Early detection of functional disorders with a dedicated platform and diagnostic device that replaces the manual examination and saves time
Decentralizing access to screening of ophthalmological and neurological conditions by introducing rapid eye examination tests
Rapid screening supports already understaffed eye care professionals to face an increase demand of eye care by providing them with a platform and diagnostic support device in which the patient does the work and can be operated by anyone
Generating objective data and clinical results to improve health outcome and research
Current Tests
Saccade Main Sequence
Objective Acuity
Objective Contrast Sensitivity
Ganglion Layer Light Adaptation
Automated Smooth Pursuit Metrics
Automated Fixation Metrics
Pro Saccades
Anti Saccades
Our Purpose
Our aim is to offer clinicians and researchers one device that can perform multiple rapid neuro-ophthalmic eye examination tests. Our unique BulbiHUB platform and BulbiCAM currently offers the user multiple tests to screen for glaucoma, age-related macular degeneration (AMD) , nystagmus, cataract and optic neuritis. Ultimately our BulbiCAM will include multiple tests to screen for both ophthalmological and neurological conditions.
Our technology maintains good vision and cognitive health across a lifetime.
BulbiCAM - Multiple rapid eye examination tests to screen for ophthalmological and neurological conditions
Benefits of Our Technology
- Rapid testing the afferent visual function and efferent system of patients
- One combined perimeter, pupillograph and nystagmograph
- Early detection of ophthalmological and neurological conditions
- Provides objective data of the afferent visual function and efferent system of patients
- Replaces manual examinations
- Patient does the work, not the clinician
- Integrates with any third party ophthalmic device
- Can be operated by ophthalmic nurse, tech staff or any other assistant
Problems We Solve
- Long and difficult process of neuro-ophthalmic examination
- Manually performing the entrance and functional eye examination
- Manually inserting test results
- Inefficient clinical workflow
- Subjective interpretation
- Lack of data during clinical decision making
- Lack of research data on eye - brain functionality
BulbiCAM
Diagnostic tool in mastering a complete neuro-ophthalmic assessment of the patient
- 400-600 FPS eyetracking
- Two screens for independent presentation to each eye
- Accurate timing synchronization
- Calibration free eye tracking test setup
- Individual compensation of refractive errors and head shape
- Can be operated remotely via internet
- CE-certified & FDA registered
Our Solution
BulbiHUB Platform
BulbiHUB platform assesses the data measured by BulbiCAM. BulbiHUB is an innovative point-of-care eye platform for the screening of ophthalmological and neurological disorders.
Telemedicine
Assessed data can be shared between and amongst clinical from peripheral locations to one central location, resulting in a clinical workflow that can continue remotely during pandemic outbreaks
AI [Artificial Intelligence]
Algorithms can be developed to detect early stage neuro- ocular dysfunctions and analyze our collected data for research purpose
News
Rigshospitalet Copenhagen is now our clinical partner
News Rigshospitalet Copenhagen is now our clinical partner The study is designed as follows: Pilot study Inclusion of 10-15 healthy children and children with known visual field defects (ages 4-12) to test the setup of the equipm ent and the possibility of detection of visual field defect. The children will also go through some basic […]
Bulbitech qualified for the semifinal of EIT Health Catapult 2022-23
News Bulbitech qualified for the semifinal of of EIT Health Catapult 2022-23 Bulbitech qualified for the semifinal of EIT Health Catapult 2022-23. This competition showcases the most promising European startups in three categories – biotech, medtech, and digital health. There are 42 companies in total and Bulbitech is selected as one of 14 most promising […]
Bulbitech AS is proud to announce Dr. Oleg Komogortsev is joining Bulbitech’s advisory board.
News Bulbitech AS is proud to announce Dr. Oleg Komogortsev is joining Bulbitech’s advisory board. After an initial meeting at NANOS 2022 and several follow-up meetings both parties became convinced that his role as an advisor with regards to topics as Artificial Intelligence, Eye Tracking signal capture and its interpretationin relation to biometric data and human computer […]
Bulbitech is amongst the Top 20 Nordic Impact-Driven AI companies & Start-ups 2022
News Bulbitech is amongst the Top 20 Nordic Impact-Driven AI companies & Start-ups 2022 Bulbitech is amongst the Top 20 Nordic Impact-Driven AI companies & Start-ups 2022, according to Omdena, a collaborative platform where the global community of AI engineers collaboratively builds real-world solutions. Thank you for your recognition. Share on facebook Facebook Share on […]
Bulbitech AS is proud to announce Michael Strupp, statutory Professor of Neurology and Clinical Neurophysiology, is joining Bulbitech’s clinical advisory board.
Bulbitech AS is proud to announce Michael Strupp, statutory Professor of Neurology and Clinical Neurophysiology, is joining Bulbitech’s clinical advisory board. Bulbitech AS is proud to announce Michael Strupp, MD, FRCP, FAAN, FEAN, FANA, statutory Professor of Neurology and Clinical Neurophysiology, is joining Bulbitech’s clinical advisory board. After an initial meeting, demo and several follow-up […]
Bulbitech AS is proud to announce Assistant Professor Kemar Green is joining Bulbitech’s clinical advisory board
News Bulbitech AS is proud to announce Assistant Professor Kemar Green is joining Bulbitech’s clinical advisory board After an initial meeting at NANOS 2022 and several follow-up meetings both parties became convinced that his role as a clinical advisor for neurological and neuro-ophthalmic guidance at Bulbitech AS is an excellent fit for both parties. Assistant […]
Bulbitech is among one of the three medtech companies to pitch in EIT Health’s European Health Catapult 2022
Article / News Bulbitech is among one of the three medtech companies to pitch in EIT Health’s European Health Catapult 2022 Bulbitech is proud to announce it has been selected as one of the three medtech companies to pitch in EIT Health’s European Health Catapult 2022 Scandinavian regional pitch competition. Share on facebook Facebook Share […]
Luka Opasic, MD, PhD has joined our team as Chief Data Officer.
News Luka Opasic, MD, PhD has joined our team as Chief Data Officer. Bulbitech is pleased to announce that Luka Opasic, MD, PhD has joined our team as Chief Data Officer. “Since the precision of modern diagnostic tools relies heavily on the quality and quantity of data used for training of AI algorithms that power […]
Bulbitech have entered into a strategic distribution agreement with Rodenstock Norge AS
Article / News Bulbitech have entered into a strategic distribution agreement with Rodenstock Norge AS Trondheim, 25th of January 2022 Bulbitech is pleased to announce that we have entered into a strategic distribution agreement with Rodenstock Norge AS. Effective from January 1st, 2022, Rodenstock Norge AS is appointed as Bulbitech’s exclusive distributor for the Norwegian […]
University Vita Salute becomes clinical research partner of Bulbitech AS
Article / News University Vita Salute becomes clinical research partner of Bulbitech AS Bulbitech is pleased to announce that we have entered into a clinical research agreement with University Vita Salute – Ospedale San Raffaele in Milan, Italy. Effective from January 14th, 2022, the University of Vita Salute will validate functional vision tests, performed with […]
Our Company
Our Timeline
2015
Funding from public funds and private investors for technology development
2016
Technical R&D development on platform & hardware
2017
Company & software CE-certified
Funding from public funds and private investors to complete smaller prototype
2019
Finalist in the DNB Healthcare prize
2020
Bulbitech wins healthcare pitching contest at Oslo Innovation Week
Certified QMS according to ISO 13485
Hardware CE-certified
2021
Bulbitech is FDA registered under number D437315
Awarded € 2 million euro grant from Norwegian Research Council for clinical validation of tests
2022
Semifinalist EIT Health Catapult 2022-2023
I find the BulbiCAM device to be fascinating and shaping the future leading trends in ophthalmology. It is simple and easy to use, modular and very ergonomic. With its advanced virtual reality technology and diagnostic and monitoring abilities for eye disorders, this will likely be a breakthrough technology in the daily practice of high turnover clinics.
Prof. Goran Petrovski
Department of Ophthalmology, Oslo University Hospital and University of Oslo, Norway, The opinions stated by Prof. Goran Petrovski are his own, and not related to the institution he works atI am impressed by the technology of your device and first of all I would like to congratulate you for trying to solve a combination of clinical problems that no device can reliably solve.